Haemonetics
181 hedge funds and large institutions have $2.22B invested in Haemonetics in 2017 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 79 increasing their positions, 54 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
8% less funds holding
Funds holding: 197 → 181 (-16)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
38% less first-time investments, than exits
New positions opened: 15 | Existing positions closed: 24
Holders
181
Holding in Top 10
2
Calls
$9K
Puts
$3K
Top Buyers
| 1 | +$255M | |
| 2 | +$31.4M | |
| 3 | +$23.8M | |
| 4 |
HM
HealthCor Management
New York
|
+$18.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$13.5M |
Top Sellers
| 1 | -$78.3M | |
| 2 | -$6.05M | |
| 3 | -$5.89M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$5.78M |
| 5 |
HA
Heartland Advisors
Milwaukee,
Wisconsin
|
-$4.2M |